Trait: major depressive disorder

Trait Information
Identifier MONDO_0002009
Description An episode of depression lasting two or more weeks without an intervening episode of mania. [NCIT: P378]
Trait category
Neurological disorder
Synonyms 11 synonyms
  • MDD
  • major depression
  • major depressive disorder
  • major depressive disorder 1
  • major depressive disorder 2
  • major depressive disorder and accelerated response to antidepressant drug treatment
  • major depressive disorder, response to citalopram therapy in
  • recurrent major depression
  • single major depressive episode
  • unipolar depression
  • unipolar depression, susceptibility to
Mapped terms 14 mapped terms
  • DOID:1470
  • EFO:0003761
  • ICD9:296.2
  • ICD9:296.20
  • ICD9:296.3
  • ICD9:296.30
  • MEDGEN:266123
  • MESH:D003865
  • MFOMD:0000143
  • NCIT:C35094
  • OMIM:608516
  • SCTID:300706003
  • SCTID:370143000
  • UMLS:C1269683

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported
Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution
GWAS
Dev
Eval
 Scoring File (FTP Link)
PGS000138
(LifetimeMDD)
 PGP000068 |
Cai N et al. Nat Genet (2020)
 Lifetime Major Depressive Disorder major depressive disorder 22,274
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000138/ScoringFiles/PGS000138.txt.gz
PGS000139
(MDDRecur)
 PGP000068 |
Cai N et al. Nat Genet (2020)
 Lifetime Major Depressive Disorder (with recurrence) recurrent,
major depressive disorder		 21,980
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000139/ScoringFiles/PGS000139.txt.gz
PGS000145
(ICD10Dep)
 PGP000068 |
Cai N et al. Nat Genet (2020)
 Depression (ICD-10 defined) major depressive disorder 21,510
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000145/ScoringFiles/PGS000145.txt.gz
PGS000193
(MDD_0.001_Coleman_2020)
 PGS000080 |
Coleman JRI et al. Mol Psychiatry (2020)
 Major depression major depressive disorder 1,138
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000193/ScoringFiles/PGS000193.txt.gz
PGS000767
(GRS14)
 PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
 Depression depressive symptom measurement,
major depressive disorder		 14
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000767/ScoringFiles/PGS000767.txt.gz
PGS000907
(PRS_MDD)
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Major depressive disorder major depressive disorder 1,773,528
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000907/ScoringFiles/PGS000907.txt.gz
PGS002759
(Depression_prscs)
 PGP000364 |
Mars N et al. Am J Hum Genet (2022)
 Depression major depressive disorder 1,091,613
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002759/ScoringFiles/PGS002759.txt.gz
PGS002789
(MDD_SDPR)
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Major depressive disorder major depressive disorder 943,784
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002789/ScoringFiles/PGS002789.txt.gz
PGS003333
(MDD-PRS)
 PGP000399 |
Fang Y et al. Biol Psychiatry (2022)
 Major Depressive Disorder major depressive disorder 1,088,415
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003333/ScoringFiles/PGS003333.txt.gz
PGS003442
(GRS8_MD)
 PGP000444 |
Petrican R et al. Sci Rep (2023)
 Major depressive disorder major depressive disorder 8
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003442/ScoringFiles/PGS003442.txt.gz
PGS003576
(AutoImpAll.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003576/ScoringFiles/PGS003576.txt.gz
PGS003577
(AutoImpOnly.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003577/ScoringFiles/PGS003577.txt.gz
PGS003578
(MTAG.All.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 4,786,322
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003578/ScoringFiles/PGS003578.txt.gz
PGS003579
(MTAG.AllDep.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 4,786,322
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003579/ScoringFiles/PGS003579.txt.gz
PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 4,786,322
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003580/ScoringFiles/PGS003580.txt.gz
PGS003581
(MTAG.Envs.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 4,861,398
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003581/ScoringFiles/PGS003581.txt.gz
PGS003582
(MTAG.FamHist.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 4,861,398
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003582/ScoringFiles/PGS003582.txt.gz
PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 4,861,398
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003583/ScoringFiles/PGS003583.txt.gz
PGS003584
(SoftImpAll.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003584/ScoringFiles/PGS003584.txt.gz
PGS003585
(SoftImpOnly.LifetimeMDD)
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Major Depressive Disorder (Lifetime) major depressive disorder 5,776,312
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003585/ScoringFiles/PGS003585.txt.gz
PGS004591
(PRS17_MDD)
 PGP000570 |
Li D et al. BMC Med (2023)
 Major depressive disorder major depressive disorder 17
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004591/ScoringFiles/PGS004591.txt.gz
PGS004759
(depression_PRSmix_eur)
 PGP000604 |
Truong B et al. Cell Genom (2024)
 Depression major depressive disorder 1,538,576
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004759/ScoringFiles/PGS004759.txt.gz
PGS004760
(depression_PRSmixPlus_eur)
 PGP000604 |
Truong B et al. Cell Genom (2024)
 Depression major depressive disorder 2,141,267
-
 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004760/ScoringFiles/PGS004760.txt.gz
PGS004885
(INTERVENE_MegaPRS_MDD)
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Major depressive disorder major depressive disorder 801,544
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004885/ScoringFiles/PGS004885.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM) 		Evaluated Score PGS Sample Set ID
(PSS) 		Performance Source Trait PGS Effect Sizes
(per SD change) 		Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM000430 PGS000138
(LifetimeMDD)
 PSS000250|
European Ancestry|
36,709 individuals
 PGP000068 |
Cai N et al. Nat Genet (2020)
 Reported Trait: Major Depressive Disorder status — AUROC: 0.5611 R²: 0.01817 Cohort —
PPM000431 PGS000139
(MDDRecur)
 PSS000250|
European Ancestry|
36,709 individuals
 PGP000068 |
Cai N et al. Nat Genet (2020)
 Reported Trait: Major Depressive Disorder status — AUROC: 0.54874 R²: 0.01097 Cohort —
PPM000437 PGS000145
(ICD10Dep)
 PSS000250|
European Ancestry|
36,709 individuals
 PGP000068 |
Cai N et al. Nat Genet (2020)
 Reported Trait: Major Depressive Disorder status — AUROC: 0.5251 R²: 0.0032 Cohort —
PPM000564 PGS000193
(MDD_0.001_Coleman_2020)
 PSS000294|
European Ancestry|
92,957 individuals
 PGS000080 |
Coleman JRI et al. Mol Psychiatry (2020)
 Reported Trait: Major depressive disorder OR: 1.179 — R²: 0.01485
Nagelkerke pseudo-R2 (increase when adding PRS to null model of covariates): 0.00785		 batch, centre, genomic prinicipal components (x6) —
PPM001972 PGS000767
(GRS14)
 PSS000984|
Multi-ancestry (including European)|
62 individuals
 PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
 Reported Trait: Bilateral Nucleus acumbens stress induced reward prediciton error change — — R²: 0.065 PCs(1-2) —
PPM001973 PGS000767
(GRS14)
 PSS000985|
Multi-ancestry (including European)|
63 individuals
 PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
 Reported Trait: Bilateral putamen stress induced reward prediciton error change — — R²: 0.074 PCs(1-2) —
PPM001974 PGS000767
(GRS14)
 PSS000986|
Multi-ancestry (including European)|
73 individuals
 PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
 Reported Trait: Bilateral nucleus acumbens volume — — R²: 0.064 PCs(1-2) —
PPM001975 PGS000767
(GRS14)
 PSS000986|
Multi-ancestry (including European)|
73 individuals
 PGP000174 |
Guffanti G et al. Transl Psychiatry (2019)
 Reported Trait: Bilateral putamen volume — — R²: 0.095 PCs(1-2) —
PPM002681 PGS000907
(PRS_MDD)
 PSS001279|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Escitalopram takers OR: 1.0 [0.92, 1.1] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002682 PGS000907
(PRS_MDD)
 PSS001284|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Venlafaxine takers OR: 1.05 [0.96, 1.15] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002684 PGS000907
(PRS_MDD)
 PSS001281|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Mirtazapine takers OR: 1.05 [0.91, 1.22] — Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20 —
PPM002685 PGS000907
(PRS_MDD)
 PSS001277|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Desvenlafaxine takers OR: 1.01 [0.91, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002686 PGS000907
(PRS_MDD)
 PSS001276|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Citalopram takers OR: 1.02 [0.9, 1.16] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002687 PGS000907
(PRS_MDD)
 PSS001280|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Fluoxetine takers OR: 1.06 [0.96, 1.17] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002688 PGS000907
(PRS_MDD)
 PSS001278|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Duloxetine takers OR: 1.06 [0.95, 1.2] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002689 PGS000907
(PRS_MDD)
 PSS001282|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Paroxetine takers OR: 1.08 [0.92, 1.26] — Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20 —
PPM002690 PGS000907
(PRS_MDD)
 PSS001243|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Sertraline takers OR: 1.06 [0.98, 1.14] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002691 PGS000907
(PRS_MDD)
 PSS001239|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Escitalopram takers OR: 1.06 [0.98, 1.15] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002692 PGS000907
(PRS_MDD)
 PSS001244|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Venlafaxine takers OR: 1.01 [0.93, 1.09] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002693 PGS000907
(PRS_MDD)
 PSS001235|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Amitriptyline takers OR: 0.96 [0.83, 1.1] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002694 PGS000907
(PRS_MDD)
 PSS001241|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Mirtazapine takers OR: 1.07 [0.93, 1.23] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002695 PGS000907
(PRS_MDD)
 PSS001237|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Desvenlafaxine takers OR: 0.97 [0.87, 1.07] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002696 PGS000907
(PRS_MDD)
 PSS001236|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Citalopram takers OR: 0.99 [0.87, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002697 PGS000907
(PRS_MDD)
 PSS001240|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Fluoxetine takers OR: 1.16 [1.04, 1.29] — Variance explained (Nagelkerke's R2*100): 0.41 sex, age at study enrollment, genetic PCs 1-20 —
PPM002698 PGS000907
(PRS_MDD)
 PSS001238|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Duloxetine takers OR: 0.98 [0.88, 1.1] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002699 PGS000907
(PRS_MDD)
 PSS001242|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dizziness in Paroxetine takers OR: 1.08 [0.93, 1.24] — Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20 —
PPM002700 PGS000907
(PRS_MDD)
 PSS001373|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Sertraline takers OR: 1.03 [0.94, 1.12] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002701 PGS000907
(PRS_MDD)
 PSS001369|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Escitalopram takers OR: 1.01 [0.9, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002702 PGS000907
(PRS_MDD)
 PSS001374|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Venlafaxine takers OR: 1.1 [1.0, 1.22] — Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20 —
PPM002703 PGS000907
(PRS_MDD)
 PSS001365|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Amitriptyline takers OR: 0.99 [0.81, 1.2] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002704 PGS000907
(PRS_MDD)
 PSS001371|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Mirtazapine takers OR: 1.03 [0.86, 1.24] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002705 PGS000907
(PRS_MDD)
 PSS001367|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Desvenlafaxine takers OR: 1.04 [0.92, 1.18] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002707 PGS000907
(PRS_MDD)
 PSS001370|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Fluoxetine takers OR: 1.06 [0.95, 1.19] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002708 PGS000907
(PRS_MDD)
 PSS001368|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Duloxetine takers OR: 0.9 [0.79, 1.04] — Variance explained (Nagelkerke's R2*100): 0.21 sex, age at study enrollment, genetic PCs 1-20 —
PPM002709 PGS000907
(PRS_MDD)
 PSS001372|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Paroxetine takers OR: 1.19 [1.0, 1.41] — Variance explained (Nagelkerke's R2*100): 0.53 sex, age at study enrollment, genetic PCs 1-20 —
PPM002710 PGS000907
(PRS_MDD)
 PSS001303|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Sertraline takers OR: 1.13 [0.97, 1.31] — Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20 —
PPM002711 PGS000907
(PRS_MDD)
 PSS001299|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Escitalopram takers OR: 0.96 [0.8, 1.14] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002712 PGS000907
(PRS_MDD)
 PSS001304|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Venlafaxine takers OR: 1.22 [1.03, 1.45] — Variance explained (Nagelkerke's R2*100): 0.51 sex, age at study enrollment, genetic PCs 1-20 —
PPM002713 PGS000907
(PRS_MDD)
 PSS001295|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Amitriptyline takers OR: 1.06 [0.8, 1.4] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002715 PGS000907
(PRS_MDD)
 PSS001297|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Desvenlafaxine takers OR: 1.0 [0.8, 1.24] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002716 PGS000907
(PRS_MDD)
 PSS001296|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Citalopram takers OR: 0.95 [0.72, 1.27] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002717 PGS000907
(PRS_MDD)
 PSS001300|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Fluoxetine takers OR: 1.3 [1.05, 1.6] — Variance explained (Nagelkerke's R2*100): 0.77 sex, age at study enrollment, genetic PCs 1-20 —
PPM002718 PGS000907
(PRS_MDD)
 PSS001298|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Duloxetine takers OR: 0.99 [0.82, 1.2] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002720 PGS000907
(PRS_MDD)
 PSS001263|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Sertraline takers OR: 1.04 [0.98, 1.11] — Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20 —
PPM002721 PGS000907
(PRS_MDD)
 PSS001259|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Escitalopram takers OR: 1.01 [0.94, 1.09] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002722 PGS000907
(PRS_MDD)
 PSS001264|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Venlafaxine takers OR: 0.98 [0.91, 1.05] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002723 PGS000907
(PRS_MDD)
 PSS001255|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Amitriptyline takers OR: 1.06 [0.95, 1.17] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002724 PGS000907
(PRS_MDD)
 PSS001261|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Mirtazapine takers OR: 1.05 [0.94, 1.17] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002725 PGS000907
(PRS_MDD)
 PSS001257|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Desvenlafaxine takers OR: 1.09 [0.99, 1.2] — Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20 —
PPM002726 PGS000907
(PRS_MDD)
 PSS001256|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Citalopram takers OR: 1.11 [1.0, 1.23] — Variance explained (Nagelkerke's R2*100): 0.23 sex, age at study enrollment, genetic PCs 1-20 —
PPM002727 PGS000907
(PRS_MDD)
 PSS001260|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Fluoxetine takers OR: 1.0 [0.92, 1.09] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002728 PGS000907
(PRS_MDD)
 PSS001258|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Duloxetine takers OR: 1.03 [0.93, 1.13] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002729 PGS000907
(PRS_MDD)
 PSS001262|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Dry mouth in Paroxetine takers OR: 0.98 [0.86, 1.1] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002730 PGS000907
(PRS_MDD)
 PSS001403|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Sertraline takers OR: 0.99 [0.92, 1.07] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002731 PGS000907
(PRS_MDD)
 PSS001399|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Escitalopram takers OR: 0.97 [0.89, 1.06] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002732 PGS000907
(PRS_MDD)
 PSS001404|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Venlafaxine takers OR: 1.04 [0.96, 1.12] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002733 PGS000907
(PRS_MDD)
 PSS001395|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Amitriptyline takers OR: 1.14 [0.96, 1.37] — Variance explained (Nagelkerke's R2*100): 0.3 sex, age at study enrollment, genetic PCs 1-20 —
PPM002734 PGS000907
(PRS_MDD)
 PSS001401|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Mirtazapine takers OR: 1.05 [0.9, 1.22] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002735 PGS000907
(PRS_MDD)
 PSS001397|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Desvenlafaxine takers OR: 0.99 [0.9, 1.1] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002736 PGS000907
(PRS_MDD)
 PSS001396|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Citalopram takers OR: 1.14 [0.99, 1.3] — Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20 —
PPM002737 PGS000907
(PRS_MDD)
 PSS001400|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Fluoxetine takers OR: 1.04 [0.94, 1.16] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002738 PGS000907
(PRS_MDD)
 PSS001398|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Duloxetine takers OR: 0.96 [0.86, 1.07] — Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20 —
PPM002739 PGS000907
(PRS_MDD)
 PSS001402|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Sweating in Paroxetine takers OR: 1.1 [0.94, 1.28] — Variance explained (Nagelkerke's R2*100): 0.17 sex, age at study enrollment, genetic PCs 1-20 —
PPM002741 PGS000907
(PRS_MDD)
 PSS001309|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Escitalopram takers OR: 1.06 [0.98, 1.15] — Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20 —
PPM002742 PGS000907
(PRS_MDD)
 PSS001314|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Venlafaxine takers OR: 1.08 [1.0, 1.17] — Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20 —
PPM002743 PGS000907
(PRS_MDD)
 PSS001305|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Amitriptyline takers OR: 1.12 [0.95, 1.31] — Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20 —
PPM002744 PGS000907
(PRS_MDD)
 PSS001311|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Mirtazapine takers OR: 1.08 [0.93, 1.25] — Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20 —
PPM002745 PGS000907
(PRS_MDD)
 PSS001307|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Desvenlafaxine takers OR: 1.06 [0.96, 1.17] — Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20 —
PPM002746 PGS000907
(PRS_MDD)
 PSS001306|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Citalopram takers OR: 1.11 [0.99, 1.25] — Variance explained (Nagelkerke's R2*100): 0.24 sex, age at study enrollment, genetic PCs 1-20 —
PPM002747 PGS000907
(PRS_MDD)
 PSS001310|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Fluoxetine takers OR: 1.06 [0.97, 1.16] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002748 PGS000907
(PRS_MDD)
 PSS001308|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Duloxetine takers OR: 1.16 [1.04, 1.29] — Variance explained (Nagelkerke's R2*100): 0.55 sex, age at study enrollment, genetic PCs 1-20 —
PPM002749 PGS000907
(PRS_MDD)
 PSS001312|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Paroxetine takers OR: 1.1 [0.96, 1.27] — Variance explained (Nagelkerke's R2*100): 0.21 sex, age at study enrollment, genetic PCs 1-20 —
PPM002750 PGS000907
(PRS_MDD)
 PSS001423|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Sertraline takers OR: 1.21 [1.03, 1.43] — Variance explained (Nagelkerke's R2*100): 0.44 sex, age at study enrollment, genetic PCs 1-20 —
PPM002751 PGS000907
(PRS_MDD)
 PSS001419|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Escitalopram takers OR: 0.96 [0.78, 1.18] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002752 PGS000907
(PRS_MDD)
 PSS001424|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Venlafaxine takers OR: 1.14 [0.96, 1.36] — Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20 —
PPM002754 PGS000907
(PRS_MDD)
 PSS001421|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Mirtazapine takers OR: 1.23 [0.88, 1.72] — Variance explained (Nagelkerke's R2*100): 0.45 sex, age at study enrollment, genetic PCs 1-20 —
PPM002755 PGS000907
(PRS_MDD)
 PSS001417|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Desvenlafaxine takers OR: 1.08 [0.86, 1.36] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002756 PGS000907
(PRS_MDD)
 PSS001416|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Citalopram takers OR: 1.19 [0.87, 1.64] — Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20 —
PPM002757 PGS000907
(PRS_MDD)
 PSS001420|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Fluoxetine takers OR: 1.01 [0.8, 1.28] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002758 PGS000907
(PRS_MDD)
 PSS001418|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Duloxetine takers OR: 1.09 [0.87, 1.35] — Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20 —
PPM002759 PGS000907
(PRS_MDD)
 PSS001422|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Paroxetine takers OR: 1.17 [0.86, 1.61] — Variance explained (Nagelkerke's R2*100): 0.3 sex, age at study enrollment, genetic PCs 1-20 —
PPM002760 PGS000907
(PRS_MDD)
 PSS001223|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Sertraline takers OR: 1.15 [1.03, 1.29] — Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20 —
PPM002761 PGS000907
(PRS_MDD)
 PSS001219|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Escitalopram takers OR: 1.16 [1.01, 1.33] — Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20 —
PPM002762 PGS000907
(PRS_MDD)
 PSS001224|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Venlafaxine takers OR: 1.19 [1.07, 1.34] — Variance explained (Nagelkerke's R2*100): 0.54 sex, age at study enrollment, genetic PCs 1-20 —
PPM002763 PGS000907
(PRS_MDD)
 PSS001215|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Amitriptyline takers OR: 1.16 [0.98, 1.37] — Variance explained (Nagelkerke's R2*100): 0.38 sex, age at study enrollment, genetic PCs 1-20 —
PPM002764 PGS000907
(PRS_MDD)
 PSS001221|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Mirtazapine takers OR: 1.08 [0.89, 1.29] — Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20 —
PPM002765 PGS000907
(PRS_MDD)
 PSS001217|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Desvenlafaxine takers OR: 1.03 [0.89, 1.2] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002767 PGS000907
(PRS_MDD)
 PSS001220|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Fluoxetine takers OR: 1.09 [0.94, 1.27] — Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20 —
PPM002768 PGS000907
(PRS_MDD)
 PSS001218|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Duloxetine takers OR: 1.02 [0.89, 1.18] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002769 PGS000907
(PRS_MDD)
 PSS001222|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Paroxetine takers OR: 1.09 [0.9, 1.31] — Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20 —
PPM002771 PGS000907
(PRS_MDD)
 PSS001229|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Escitalopram takers OR: 1.01 [0.89, 1.16] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002772 PGS000907
(PRS_MDD)
 PSS001234|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Venlafaxine takers OR: 1.13 [0.97, 1.32] — Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20 —
PPM002773 PGS000907
(PRS_MDD)
 PSS001225|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Amitriptyline takers OR: 1.02 [0.73, 1.42] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002774 PGS000907
(PRS_MDD)
 PSS001231|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Mirtazapine takers OR: 1.13 [0.89, 1.42] — Variance explained (Nagelkerke's R2*100): 0.18 sex, age at study enrollment, genetic PCs 1-20 —
PPM002775 PGS000907
(PRS_MDD)
 PSS001227|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Desvenlafaxine takers OR: 1.01 [0.84, 1.21] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002776 PGS000907
(PRS_MDD)
 PSS001226|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Citalopram takers OR: 0.95 [0.76, 1.19] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002777 PGS000907
(PRS_MDD)
 PSS001230|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Fluoxetine takers OR: 0.99 [0.84, 1.17] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002778 PGS000907
(PRS_MDD)
 PSS001228|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Duloxetine takers OR: 1.08 [0.9, 1.3] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002779 PGS000907
(PRS_MDD)
 PSS001232|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Paroxetine takers OR: 1.47 [1.13, 1.91] — Variance explained (Nagelkerke's R2*100): 1.92 sex, age at study enrollment, genetic PCs 1-20 —
PPM002780 PGS000907
(PRS_MDD)
 PSS001253|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Sertraline takers OR: 1.01 [0.94, 1.09] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002782 PGS000907
(PRS_MDD)
 PSS001254|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Venlafaxine takers OR: 1.0 [0.91, 1.1] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002783 PGS000907
(PRS_MDD)
 PSS001245|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Amitriptyline takers OR: 0.99 [0.89, 1.11] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002784 PGS000907
(PRS_MDD)
 PSS001251|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Mirtazapine takers OR: 1.06 [0.96, 1.18] — Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20 —
PPM002785 PGS000907
(PRS_MDD)
 PSS001247|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Desvenlafaxine takers OR: 0.99 [0.88, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002786 PGS000907
(PRS_MDD)
 PSS001246|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Citalopram takers OR: 1.05 [0.93, 1.18] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002787 PGS000907
(PRS_MDD)
 PSS001250|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Fluoxetine takers OR: 1.04 [0.94, 1.14] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002788 PGS000907
(PRS_MDD)
 PSS001248|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Duloxetine takers OR: 0.96 [0.86, 1.08] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002789 PGS000907
(PRS_MDD)
 PSS001252|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Paroxetine takers OR: 0.97 [0.83, 1.12] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002790 PGS000907
(PRS_MDD)
 PSS001413|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Sertraline takers OR: 1.04 [0.97, 1.12] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002791 PGS000907
(PRS_MDD)
 PSS001409|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Escitalopram takers OR: 1.02 [0.94, 1.1] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002792 PGS000907
(PRS_MDD)
 PSS001414|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Venlafaxine takers OR: 1.02 [0.94, 1.1] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002793 PGS000907
(PRS_MDD)
 PSS001405|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Amitriptyline takers OR: 1.05 [0.88, 1.26] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002794 PGS000907
(PRS_MDD)
 PSS001411|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Mirtazapine takers OR: 1.13 [0.97, 1.32] — Variance explained (Nagelkerke's R2*100): 0.27 sex, age at study enrollment, genetic PCs 1-20 —
PPM002795 PGS000907
(PRS_MDD)
 PSS001407|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Desvenlafaxine takers OR: 1.05 [0.95, 1.16] — Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20 —
PPM002796 PGS000907
(PRS_MDD)
 PSS001406|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Citalopram takers OR: 1.0 [0.89, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002797 PGS000907
(PRS_MDD)
 PSS001410|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Fluoxetine takers OR: 1.05 [0.96, 1.15] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002798 PGS000907
(PRS_MDD)
 PSS001408|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Duloxetine takers OR: 0.97 [0.87, 1.09] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002800 PGS000907
(PRS_MDD)
 PSS001203|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Sertraline takers OR: 1.13 [1.04, 1.22] — Variance explained (Nagelkerke's R2*100): 0.29 sex, age at study enrollment, genetic PCs 1-20 —
PPM002801 PGS000907
(PRS_MDD)
 PSS001199|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Escitalopram takers OR: 1.01 [0.91, 1.11] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002802 PGS000907
(PRS_MDD)
 PSS001204|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Venlafaxine takers OR: 1.14 [1.04, 1.26] — Variance explained (Nagelkerke's R2*100): 0.36 sex, age at study enrollment, genetic PCs 1-20 —
PPM002803 PGS000907
(PRS_MDD)
 PSS001195|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Amitriptyline takers OR: 1.05 [0.87, 1.27] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002804 PGS000907
(PRS_MDD)
 PSS001201|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Mirtazapine takers OR: 1.2 [1.03, 1.39] — Variance explained (Nagelkerke's R2*100): 0.59 sex, age at study enrollment, genetic PCs 1-20 —
PPM002805 PGS000907
(PRS_MDD)
 PSS001197|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Desvenlafaxine takers OR: 1.04 [0.92, 1.17] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002806 PGS000907
(PRS_MDD)
 PSS001196|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Citalopram takers OR: 0.97 [0.85, 1.12] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002807 PGS000907
(PRS_MDD)
 PSS001200|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Fluoxetine takers OR: 1.05 [0.96, 1.16] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002808 PGS000907
(PRS_MDD)
 PSS001198|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Duloxetine takers OR: 1.0 [0.87, 1.14] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002809 PGS000907
(PRS_MDD)
 PSS001202|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Anxiety in Paroxetine takers OR: 1.1 [0.94, 1.29] — Variance explained (Nagelkerke's R2*100): 0.19 sex, age at study enrollment, genetic PCs 1-20 —
PPM002810 PGS000907
(PRS_MDD)
 PSS001193|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Sertraline takers OR: 1.04 [0.96, 1.13] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002811 PGS000907
(PRS_MDD)
 PSS001189|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Escitalopram takers OR: 1.06 [0.96, 1.17] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002812 PGS000907
(PRS_MDD)
 PSS001194|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Venlafaxine takers OR: 1.06 [0.97, 1.17] — Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20 —
PPM002813 PGS000907
(PRS_MDD)
 PSS001185|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Amitriptyline takers OR: 1.02 [0.85, 1.23] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002814 PGS000907
(PRS_MDD)
 PSS001191|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Mirtazapine takers OR: 1.25 [1.08, 1.46] — Variance explained (Nagelkerke's R2*100): 0.93 sex, age at study enrollment, genetic PCs 1-20 —
PPM002816 PGS000907
(PRS_MDD)
 PSS001186|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Citalopram takers OR: 1.05 [0.91, 1.21] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002817 PGS000907
(PRS_MDD)
 PSS001190|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Fluoxetine takers OR: 1.06 [0.96, 1.18] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002818 PGS000907
(PRS_MDD)
 PSS001188|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Duloxetine takers OR: 1.05 [0.91, 1.21] — Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20 —
PPM002819 PGS000907
(PRS_MDD)
 PSS001192|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Paroxetine takers OR: 1.19 [1.02, 1.38] — Variance explained (Nagelkerke's R2*100): 0.6 sex, age at study enrollment, genetic PCs 1-20 —
PPM002820 PGS000907
(PRS_MDD)
 PSS001273|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Sertraline takers OR: 1.01 [0.94, 1.09] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002821 PGS000907
(PRS_MDD)
 PSS001269|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Escitalopram takers OR: 0.96 [0.88, 1.05] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002822 PGS000907
(PRS_MDD)
 PSS001274|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Venlafaxine takers OR: 1.06 [0.97, 1.16] — Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20 —
PPM002823 PGS000907
(PRS_MDD)
 PSS001265|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Amitriptyline takers OR: 1.12 [0.97, 1.28] — Variance explained (Nagelkerke's R2*100): 0.25 sex, age at study enrollment, genetic PCs 1-20 —
PPM002824 PGS000907
(PRS_MDD)
 PSS001271|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Mirtazapine takers OR: 1.06 [0.94, 1.2] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002826 PGS000907
(PRS_MDD)
 PSS001266|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Citalopram takers OR: 0.98 [0.86, 1.11] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002827 PGS000907
(PRS_MDD)
 PSS001270|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Fluoxetine takers OR: 1.02 [0.92, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002829 PGS000907
(PRS_MDD)
 PSS001272|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Paroxetine takers OR: 0.96 [0.82, 1.11] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002831 PGS000907
(PRS_MDD)
 PSS001429|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Escitalopram takers OR: 1.04 [0.97, 1.11] — Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20 —
PPM002832 PGS000907
(PRS_MDD)
 PSS001434|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Venlafaxine takers OR: 1.03 [0.96, 1.11] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002833 PGS000907
(PRS_MDD)
 PSS001425|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Amitriptyline takers OR: 1.06 [0.95, 1.19] — Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20 —
PPM002834 PGS000907
(PRS_MDD)
 PSS001431|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Mirtazapine takers OR: 1.02 [0.93, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002835 PGS000907
(PRS_MDD)
 PSS001427|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Desvenlafaxine takers OR: 1.11 [1.02, 1.22] — Variance explained (Nagelkerke's R2*100): 0.33 sex, age at study enrollment, genetic PCs 1-20 —
PPM002836 PGS000907
(PRS_MDD)
 PSS001426|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Citalopram takers OR: 1.14 [1.03, 1.25] — Variance explained (Nagelkerke's R2*100): 0.4 sex, age at study enrollment, genetic PCs 1-20 —
PPM002837 PGS000907
(PRS_MDD)
 PSS001430|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Fluoxetine takers OR: 1.04 [0.96, 1.12] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002838 PGS000907
(PRS_MDD)
 PSS001428|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Duloxetine takers OR: 1.0 [0.91, 1.1] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002839 PGS000907
(PRS_MDD)
 PSS001432|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Paroxetine takers OR: 1.11 [0.99, 1.24] — Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20 —
PPM002840 PGS000907
(PRS_MDD)
 PSS001443|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Sertraline takers OR: 0.9 [0.75, 1.07] — Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20 —
PPM002841 PGS000907
(PRS_MDD)
 PSS001439|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Escitalopram takers OR: 1.07 [0.88, 1.32] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002842 PGS000907
(PRS_MDD)
 PSS001444|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Venlafaxine takers OR: 1.05 [0.84, 1.3] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002844 PGS000907
(PRS_MDD)
 PSS001441|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Mirtazapine takers OR: 1.21 [0.85, 1.71] — Variance explained (Nagelkerke's R2*100): 0.37 sex, age at study enrollment, genetic PCs 1-20 —
PPM002845 PGS000907
(PRS_MDD)
 PSS001437|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Desvenlafaxine takers OR: 0.95 [0.74, 1.22] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002846 PGS000907
(PRS_MDD)
 PSS001436|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Citalopram takers OR: 0.87 [0.61, 1.23] — Variance explained (Nagelkerke's R2*100): 0.19 sex, age at study enrollment, genetic PCs 1-20 —
PPM002847 PGS000907
(PRS_MDD)
 PSS001440|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Fluoxetine takers OR: 1.16 [0.96, 1.39] — Variance explained (Nagelkerke's R2*100): 0.26 sex, age at study enrollment, genetic PCs 1-20 —
PPM002848 PGS000907
(PRS_MDD)
 PSS001438|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Duloxetine takers OR: 0.96 [0.75, 1.23] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002849 PGS000907
(PRS_MDD)
 PSS001442|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Paroxetine takers OR: 1.36 [0.88, 2.1] — Variance explained (Nagelkerke's R2*100): 0.99 sex, age at study enrollment, genetic PCs 1-20 —
PPM002852 PGS000907
(PRS_MDD)
 PSS001344|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Venlafaxine takers OR: 1.0 [0.74, 1.36] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002853 PGS000907
(PRS_MDD)
 PSS001335|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Amitriptyline takers OR: 1.22 [0.73, 2.04] — Variance explained (Nagelkerke's R2*100): 0.42 sex, age at study enrollment, genetic PCs 1-20 —
PPM002854 PGS000907
(PRS_MDD)
 PSS001341|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Mirtazapine takers OR: 1.0 [0.65, 1.52] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002855 PGS000907
(PRS_MDD)
 PSS001337|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Desvenlafaxine takers OR: 1.58 [1.13, 2.23] — Variance explained (Nagelkerke's R2*100): 2.19 sex, age at study enrollment, genetic PCs 1-20 —
PPM002856 PGS000907
(PRS_MDD)
 PSS001336|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Citalopram takers OR: 1.1 [0.7, 1.74] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002857 PGS000907
(PRS_MDD)
 PSS001340|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Fluoxetine takers OR: 1.34 [0.91, 1.97] — Variance explained (Nagelkerke's R2*100): 0.75 sex, age at study enrollment, genetic PCs 1-20 —
PPM002858 PGS000907
(PRS_MDD)
 PSS001338|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Duloxetine takers OR: 1.13 [0.75, 1.7] — Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20 —
PPM002859 PGS000907
(PRS_MDD)
 PSS001342|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Paroxetine takers OR: 1.16 [0.69, 1.95] — Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20 —
PPM002860 PGS000907
(PRS_MDD)
 PSS001363|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Sertraline takers OR: 1.0 [0.79, 1.28] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002861 PGS000907
(PRS_MDD)
 PSS001359|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Escitalopram takers OR: 0.91 [0.69, 1.19] — Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20 —
PPM002862 PGS000907
(PRS_MDD)
 PSS001364|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Venlafaxine takers OR: 1.06 [0.8, 1.42] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002863 PGS000907
(PRS_MDD)
 PSS001355|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Amitriptyline takers OR: 0.59 [0.36, 0.98] — Variance explained (Nagelkerke's R2*100): 2.43 sex, age at study enrollment, genetic PCs 1-20 —
PPM002864 PGS000907
(PRS_MDD)
 PSS001361|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Mirtazapine takers OR: 0.85 [0.55, 1.3] — Variance explained (Nagelkerke's R2*100): 0.25 sex, age at study enrollment, genetic PCs 1-20 —
PPM002865 PGS000907
(PRS_MDD)
 PSS001357|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Desvenlafaxine takers OR: 0.8 [0.59, 1.07] — Variance explained (Nagelkerke's R2*100): 0.58 sex, age at study enrollment, genetic PCs 1-20 —
PPM002868 PGS000907
(PRS_MDD)
 PSS001358|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Duloxetine takers OR: 0.99 [0.71, 1.38] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002869 PGS000907
(PRS_MDD)
 PSS001362|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Paroxetine takers OR: 0.9 [0.53, 1.52] — Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20 —
PPM002870 PGS000907
(PRS_MDD)
 PSS001353|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Sertraline takers OR: 1.0 [0.95, 1.06] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002871 PGS000907
(PRS_MDD)
 PSS001349|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Escitalopram takers OR: 0.99 [0.93, 1.06] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002872 PGS000907
(PRS_MDD)
 PSS001354|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Venlafaxine takers OR: 1.05 [0.99, 1.13] — Variance explained (Nagelkerke's R2*100): 0.09 sex, age at study enrollment, genetic PCs 1-20 —
PPM002873 PGS000907
(PRS_MDD)
 PSS001345|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Amitriptyline takers OR: 1.08 [0.96, 1.22] — Variance explained (Nagelkerke's R2*100): 0.16 sex, age at study enrollment, genetic PCs 1-20 —
PPM002878 PGS000907
(PRS_MDD)
 PSS001348|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Duloxetine takers OR: 0.99 [0.91, 1.09] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002879 PGS000907
(PRS_MDD)
 PSS001352|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Paroxetine takers OR: 1.0 [0.9, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002883 PGS000907
(PRS_MDD)
 PSS001205|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Amitriptyline takers OR: 1.08 [0.86, 1.36] — Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20 —
PPM002884 PGS000907
(PRS_MDD)
 PSS001211|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Mirtazapine takers OR: 1.05 [0.84, 1.31] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002885 PGS000907
(PRS_MDD)
 PSS001207|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Desvenlafaxine takers OR: 1.13 [0.94, 1.37] — Variance explained (Nagelkerke's R2*100): 0.22 sex, age at study enrollment, genetic PCs 1-20 —
PPM002886 PGS000907
(PRS_MDD)
 PSS001206|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Citalopram takers OR: 1.39 [1.08, 1.79] — Variance explained (Nagelkerke's R2*100): 1.2 sex, age at study enrollment, genetic PCs 1-20 —
PPM002887 PGS000907
(PRS_MDD)
 PSS001210|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Fluoxetine takers OR: 1.03 [0.85, 1.24] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002888 PGS000907
(PRS_MDD)
 PSS001208|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Duloxetine takers OR: 1.04 [0.87, 1.26] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002889 PGS000907
(PRS_MDD)
 PSS001212|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Paroxetine takers OR: 1.32 [1.0, 1.75] — Variance explained (Nagelkerke's R2*100): 0.99 sex, age at study enrollment, genetic PCs 1-20 —
PPM002890 PGS000907
(PRS_MDD)
 PSS001393|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Sertraline takers OR: 1.24 [1.14, 1.34] — Variance explained (Nagelkerke's R2*100): 0.9 sex, age at study enrollment, genetic PCs 1-20 —
PPM002894 PGS000907
(PRS_MDD)
 PSS001391|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Mirtazapine takers OR: 1.09 [0.94, 1.25] — Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20 —
PPM002895 PGS000907
(PRS_MDD)
 PSS001387|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Desvenlafaxine takers OR: 1.06 [0.94, 1.2] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002896 PGS000907
(PRS_MDD)
 PSS001386|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Citalopram takers OR: 1.06 [0.92, 1.22] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002897 PGS000907
(PRS_MDD)
 PSS001390|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Fluoxetine takers OR: 1.12 [1.02, 1.23] — Variance explained (Nagelkerke's R2*100): 0.27 sex, age at study enrollment, genetic PCs 1-20 —
PPM002898 PGS000907
(PRS_MDD)
 PSS001388|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Duloxetine takers OR: 0.98 [0.86, 1.12] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002899 PGS000907
(PRS_MDD)
 PSS001392|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Paroxetine takers OR: 1.22 [1.05, 1.42] — Variance explained (Nagelkerke's R2*100): 0.8 sex, age at study enrollment, genetic PCs 1-20 —
PPM002900 PGS000907
(PRS_MDD)
 PSS001383|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Sertraline takers OR: 1.15 [1.01, 1.31] — Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20 —
PPM002901 PGS000907
(PRS_MDD)
 PSS001379|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Escitalopram takers OR: 1.06 [0.9, 1.24] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002902 PGS000907
(PRS_MDD)
 PSS001384|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Venlafaxine takers OR: 1.36 [1.18, 1.58] — Variance explained (Nagelkerke's R2*100): 1.35 sex, age at study enrollment, genetic PCs 1-20 —
PPM002903 PGS000907
(PRS_MDD)
 PSS001375|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Amitriptyline takers OR: 0.97 [0.75, 1.24] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002904 PGS000907
(PRS_MDD)
 PSS001381|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Mirtazapine takers OR: 1.11 [0.88, 1.4] — Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20 —
PPM002905 PGS000907
(PRS_MDD)
 PSS001377|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Desvenlafaxine takers OR: 0.97 [0.78, 1.21] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002906 PGS000907
(PRS_MDD)
 PSS001376|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Citalopram takers OR: 0.96 [0.76, 1.21] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002907 PGS000907
(PRS_MDD)
 PSS001380|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Fluoxetine takers OR: 1.09 [0.95, 1.26] — Variance explained (Nagelkerke's R2*100): 0.11 sex, age at study enrollment, genetic PCs 1-20 —
PPM002908 PGS000907
(PRS_MDD)
 PSS001378|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Duloxetine takers OR: 1.11 [0.89, 1.38] — Variance explained (Nagelkerke's R2*100): 0.15 sex, age at study enrollment, genetic PCs 1-20 —
PPM002909 PGS000907
(PRS_MDD)
 PSS001382|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide attempt in Paroxetine takers OR: 1.22 [0.95, 1.55] — Variance explained (Nagelkerke's R2*100): 0.54 sex, age at study enrollment, genetic PCs 1-20 —
PPM002910 PGS000907
(PRS_MDD)
 PSS001333|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Sertraline takers OR: 0.99 [0.91, 1.09] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002911 PGS000907
(PRS_MDD)
 PSS001329|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Escitalopram takers OR: 0.96 [0.86, 1.07] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002912 PGS000907
(PRS_MDD)
 PSS001334|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Venlafaxine takers OR: 1.14 [1.03, 1.27] — Variance explained (Nagelkerke's R2*100): 0.31 sex, age at study enrollment, genetic PCs 1-20 —
PPM002913 PGS000907
(PRS_MDD)
 PSS001325|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Amitriptyline takers OR: 1.07 [0.88, 1.29] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002914 PGS000907
(PRS_MDD)
 PSS001331|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Mirtazapine takers OR: 1.03 [0.87, 1.2] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002915 PGS000907
(PRS_MDD)
 PSS001327|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Desvenlafaxine takers OR: 1.02 [0.88, 1.18] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002916 PGS000907
(PRS_MDD)
 PSS001326|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Citalopram takers OR: 0.95 [0.82, 1.1] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002917 PGS000907
(PRS_MDD)
 PSS001330|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Fluoxetine takers OR: 1.05 [0.93, 1.18] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002918 PGS000907
(PRS_MDD)
 PSS001328|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Duloxetine takers OR: 1.04 [0.89, 1.2] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002919 PGS000907
(PRS_MDD)
 PSS001332|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Other side effects in Paroxetine takers OR: 0.97 [0.81, 1.16] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002920 PGS000907
(PRS_MDD)
 PSS001323|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Sertraline takers OR: 1.04 [0.89, 1.21] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002921 PGS000907
(PRS_MDD)
 PSS001319|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Escitalopram takers OR: 1.04 [0.89, 1.22] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002922 PGS000907
(PRS_MDD)
 PSS001324|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Venlafaxine takers OR: 0.94 [0.79, 1.12] — Variance explained (Nagelkerke's R2*100): 0.05 sex, age at study enrollment, genetic PCs 1-20 —
PPM002923 PGS000907
(PRS_MDD)
 PSS001315|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Amitriptyline takers OR: 1.03 [0.84, 1.25] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002924 PGS000907
(PRS_MDD)
 PSS001321|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Mirtazapine takers OR: 1.05 [0.83, 1.33] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002925 PGS000907
(PRS_MDD)
 PSS001317|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Desvenlafaxine takers OR: 0.82 [0.68, 0.98] — Variance explained (Nagelkerke's R2*100): 0.6 sex, age at study enrollment, genetic PCs 1-20 —
PPM002680 PGS000907
(PRS_MDD)
 PSS001283|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Sertraline takers OR: 1.03 [0.95, 1.11] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002683 PGS000907
(PRS_MDD)
 PSS001275|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Headaches in Amitriptyline takers OR: 0.96 [0.81, 1.12] — Variance explained (Nagelkerke's R2*100): 0.04 sex, age at study enrollment, genetic PCs 1-20 —
PPM002706 PGS000907
(PRS_MDD)
 PSS001366|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Shakes in Citalopram takers OR: 1.16 [0.98, 1.38] — Variance explained (Nagelkerke's R2*100): 0.32 sex, age at study enrollment, genetic PCs 1-20 —
PPM002714 PGS000907
(PRS_MDD)
 PSS001301|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Mirtazapine takers OR: 1.13 [0.9, 1.43] — Variance explained (Nagelkerke's R2*100): 0.2 sex, age at study enrollment, genetic PCs 1-20 —
PPM002719 PGS000907
(PRS_MDD)
 PSS001302|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Muscle pain in Paroxetine takers OR: 1.18 [0.87, 1.61] — Variance explained (Nagelkerke's R2*100): 0.34 sex, age at study enrollment, genetic PCs 1-20 —
PPM002740 PGS000907
(PRS_MDD)
 PSS001313|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Nausea in Sertraline takers OR: 1.08 [1.01, 1.15] — Variance explained (Nagelkerke's R2*100): 0.13 sex, age at study enrollment, genetic PCs 1-20 —
PPM002753 PGS000907
(PRS_MDD)
 PSS001415|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Vomit in Amitriptyline takers OR: 0.93 [0.65, 1.33] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002766 PGS000907
(PRS_MDD)
 PSS001216|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Constipation in Citalopram takers OR: 1.02 [0.85, 1.22] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002770 PGS000907
(PRS_MDD)
 PSS001233|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Diarrhoea in Sertraline takers OR: 1.05 [0.94, 1.16] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002781 PGS000907
(PRS_MDD)
 PSS001249|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Drowsiness in Escitalopram takers OR: 0.96 [0.89, 1.05] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002799 PGS000907
(PRS_MDD)
 PSS001412|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Trouble sleeping in Paroxetine takers OR: 1.06 [0.92, 1.22] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002815 PGS000907
(PRS_MDD)
 PSS001187|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Agitation in Desvenlafaxine takers OR: 1.07 [0.94, 1.21] — Variance explained (Nagelkerke's R2*100): 0.08 sex, age at study enrollment, genetic PCs 1-20 —
PPM002825 PGS000907
(PRS_MDD)
 PSS001267|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Desvenlafaxine takers OR: 1.02 [0.91, 1.15] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002828 PGS000907
(PRS_MDD)
 PSS001268|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Fatigue in Duloxetine takers OR: 0.93 [0.83, 1.04] — Variance explained (Nagelkerke's R2*100): 0.14 sex, age at study enrollment, genetic PCs 1-20 —
PPM002830 PGS000907
(PRS_MDD)
 PSS001433|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight gain in Sertraline takers OR: 1.02 [0.96, 1.08] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002843 PGS000907
(PRS_MDD)
 PSS001435|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Weight loss in Amitriptyline takers OR: 1.09 [0.67, 1.78] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002850 PGS000907
(PRS_MDD)
 PSS001343|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Sertraline takers OR: 1.04 [0.8, 1.36] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002851 PGS000907
(PRS_MDD)
 PSS001339|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Rashes in Escitalopram takers OR: 1.09 [0.79, 1.5] — Variance explained (Nagelkerke's R2*100): 0.07 sex, age at study enrollment, genetic PCs 1-20 —
PPM002866 PGS000907
(PRS_MDD)
 PSS001356|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Citalopram takers OR: 1.05 [0.73, 1.51] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002867 PGS000907
(PRS_MDD)
 PSS001360|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Runny nose in Fluoxetine takers OR: 1.03 [0.76, 1.4] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002874 PGS000907
(PRS_MDD)
 PSS001351|
European Ancestry|
1,987 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Mirtazapine takers OR: 0.99 [0.9, 1.1] — Variance explained (Nagelkerke's R2*100): 0.0 sex, age at study enrollment, genetic PCs 1-20 —
PPM002875 PGS000907
(PRS_MDD)
 PSS001347|
European Ancestry|
2,524 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Desvenlafaxine takers OR: 1.11 [1.02, 1.21] — Variance explained (Nagelkerke's R2*100): 0.34 sex, age at study enrollment, genetic PCs 1-20 —
PPM002876 PGS000907
(PRS_MDD)
 PSS001346|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Citalopram takers OR: 1.1 [1.01, 1.2] — Variance explained (Nagelkerke's R2*100): 0.28 sex, age at study enrollment, genetic PCs 1-20 —
PPM002877 PGS000907
(PRS_MDD)
 PSS001350|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Reduced sexual desire in Fluoxetine takers OR: 1.05 [0.98, 1.12] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002880 PGS000907
(PRS_MDD)
 PSS001213|
European Ancestry|
5,719 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Sertraline takers OR: 0.96 [0.83, 1.11] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002881 PGS000907
(PRS_MDD)
 PSS001209|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Escitalopram takers OR: 1.03 [0.87, 1.22] — Variance explained (Nagelkerke's R2*100): 0.01 sex, age at study enrollment, genetic PCs 1-20 —
PPM002882 PGS000907
(PRS_MDD)
 PSS001214|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Blurry vision in Venlafaxine takers OR: 0.97 [0.84, 1.12] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM002891 PGS000907
(PRS_MDD)
 PSS001389|
European Ancestry|
4,365 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Escitalopram takers OR: 1.09 [0.99, 1.2] — Variance explained (Nagelkerke's R2*100): 0.15 sex, age at study enrollment, genetic PCs 1-20 —
PPM002892 PGS000907
(PRS_MDD)
 PSS001394|
European Ancestry|
3,967 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Venlafaxine takers OR: 1.19 [1.09, 1.31] — Variance explained (Nagelkerke's R2*100): 0.63 sex, age at study enrollment, genetic PCs 1-20 —
PPM002893 PGS000907
(PRS_MDD)
 PSS001385|
European Ancestry|
1,657 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: Suicide thoughts in Amitriptyline takers OR: 0.94 [0.8, 1.11] — Variance explained (Nagelkerke's R2*100): 0.06 sex, age at study enrollment, genetic PCs 1-20 —
PPM002926 PGS000907
(PRS_MDD)
 PSS001316|
European Ancestry|
2,585 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Citalopram takers OR: 1.08 [0.92, 1.28] — Variance explained (Nagelkerke's R2*100): 0.1 sex, age at study enrollment, genetic PCs 1-20 —
PPM002927 PGS000907
(PRS_MDD)
 PSS001320|
European Ancestry|
3,670 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Fluoxetine takers OR: 1.05 [0.91, 1.21] — Variance explained (Nagelkerke's R2*100): 0.03 sex, age at study enrollment, genetic PCs 1-20 —
PPM002928 PGS000907
(PRS_MDD)
 PSS001318|
European Ancestry|
1,995 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Duloxetine takers OR: 0.91 [0.74, 1.13] — Variance explained (Nagelkerke's R2*100): 0.12 sex, age at study enrollment, genetic PCs 1-20 —
PPM002929 PGS000907
(PRS_MDD)
 PSS001322|
European Ancestry|
1,580 individuals
 PGP000238 |
Campos AI et al. Commun Med (Lond) (2021)
 Reported Trait: No side effects in Paroxetine takers OR: 0.97 [0.77, 1.22] — Variance explained (Nagelkerke's R2*100): 0.02 sex, age at study enrollment, genetic PCs 1-20 —
PPM014959 PGS002759
(Depression_prscs)
 PSS009939|
European Ancestry|
39,444 individuals
 PGP000364 |
Mars N et al. Am J Hum Genet (2022)
 Reported Trait: Depression OR: 1.26 [1.22, 1.3] — — age, sex, 10 PCs, technical covariates —
PPM015246 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (rule breaking) — — partial R²: 0.00268 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015300 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Cognitive total) — — partial R²: 0.00106 age, PCs1-3 —
PPM015241 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (withdrawn) — — partial R²: 0.00533 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015242 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (somatic symptoms) — — partial R²: 0.00626 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015243 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (social problems) — — partial R²: 0.00358 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015244 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (thought problems) — — partial R²: 0.00276 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015247 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (aggressive behaviour) — — partial R²: 0.00203 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015248 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (internalising) — — partial R²: 0.00815 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015249 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (externalising) — — partial R²: 0.00246 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015250 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (total problems) — — partial R²: 0.00528 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015251 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 depression) — — partial R²: 0.00752 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015252 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 anxety disorder) — — partial R²: 0.00657 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015253 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 somatic problem) — — partial R²: 0.00516 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015254 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 adhd) — — partial R²: 0.00088 age, PCs1-3 —
PPM015255 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 opppsit) — — partial R²: 0.00172 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015256 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 conduct) — — partial R²: 0.00205 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015257 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Sluggish cognitive tempo) — — partial R²: 0.0067 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015258 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Obsessive compulsive disorder) — — partial R²: 0.00297 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015259 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (stress) — — partial R²: 0.00464 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015260 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Picture vocabulary) — — partial R²: 0.00077 age, PCs1-3 —
PPM015261 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Flanker test) — — partial R²: 7e-05 age, PCs1-3 —
PPM015262 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (list sorting) — — partial R²: 0.00112 age, PCs1-3 —
PPM015263 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (card sorting) — — partial R²: 0.00064 age, PCs1-3 —
PPM015264 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (pattern comparison) — — partial R²: 0.00012 age, PCs1-3 —
PPM015265 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Picture sequence) — — partial R²: 0.00045 age, PCs1-3 —
PPM015266 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (reading) — — partial R²: 0.00281 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015267 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (fluid composite) — — partial R²: 0.00047 age, PCs1-3 —
PPM015268 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Crystallized composite) — — partial R²: 0.00222 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015269 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Cognitive total) — — partial R²: 0.00155 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015270 PGS002789
(MDD_SDPR)
 PSS009953|
European Ancestry|
68,614 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (fluid composite) — — partial R²: 0.00137 age, PCs1-10 the observed partial R² were higher than random R²s
PPM015271 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (anxious/depressed) — — partial R²: 0.00213 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015272 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (withdrawn) — — partial R²: 0.00201 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015273 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (somatic symptoms) — — partial R²: 0.00469 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015274 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (social problems) — — partial R²: 0.00414 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015275 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (thought problems) — — partial R²: 0.00322 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015276 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (attention problems) — — partial R²: 0.00218 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015277 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (rule breaking) — — partial R²: 0.00165 age, PCs1-3 —
PPM015279 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (internalising) — — partial R²: 0.00397 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015280 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (externalising) — — partial R²: 0.00439 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015281 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (total problems) — — partial R²: 0.00566 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015282 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 depression) — — partial R²: 0.00515 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015283 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 anxety disorder) — — partial R²: 0.00335 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015284 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 somatic problem) — — partial R²: 0.00266 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015285 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 adhd) — — partial R²: 0.00154 age, PCs1-3 —
PPM015286 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 opppsit) — — partial R²: 0.00642 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015287 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Dsm5 conduct) — — partial R²: 0.00155 age, PCs1-3 —
PPM015288 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Sluggish cognitive tempo) — — partial R²: 0.00254 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015289 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (Obsessive compulsive disorder) — — partial R²: 0.00049 age, PCs1-3 —
PPM015290 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (stress) — — partial R²: 0.0055 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015291 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Picture vocabulary) — — partial R²: 0.00143 age, PCs1-3 —
PPM015292 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Flanker test) — — partial R²: 0.00019 age, PCs1-3 —
PPM015293 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (list sorting) — — partial R²: 0.00068 age, PCs1-3 —
PPM015294 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (card sorting) — — partial R²: 6e-05 age, PCs1-3 —
PPM015295 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (pattern comparison) — — partial R²: 5e-05 age, PCs1-3 —
PPM015296 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Picture sequence) — — partial R²: 0.00048 age, PCs1-3 —
PPM015297 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (reading) — — partial R²: 0.00014 age, PCs1-3 —
PPM015301 PGS002789
(MDD_SDPR)
 PSS009951|
European Ancestry|
78,561 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (fluid composite) — — partial R²: 0.00137 age, PCs1-10 the observed partial R² were higher than random R²s
PPM015422 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Genu of corpus callosum — — partial R²: 0.00139 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015423 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Body of corpus callosum — — partial R²: 0.00095 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015424 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior limb of internal capsule R — — partial R²: 0.00161 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015425 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior limb of internal capsule L — — partial R²: 0.00093 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015426 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Posterior limb of internal capsule R — — partial R²: 0.0008 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015427 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior corona radiata R — — partial R²: 0.00087 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015428 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior corona radiata L — — partial R²: 0.00092 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015429 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cingulum cingulate gyrus R — — partial R²: 0.00105 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015430 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior frontooccipital fasciculus R — — partial R²: 0.00096 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015431 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Genu of corpus callosum — — partial R²: 0.00106 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015432 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Body of corpus callosum — — partial R²: 0.00123 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015433 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior limb of internal capsule R — — partial R²: 0.00155 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015434 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior corona radiata R — — partial R²: 0.00097 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015435 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior corona radiata L — — partial R²: 0.00097 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015436 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior corona radiata R — — partial R²: 0.00146 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015437 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior corona radiata L — — partial R²: 0.00099 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015438 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior longitudinal fasciculus R — — partial R²: 0.00094 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015439 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior longitudinal fasciculus L — — partial R²: 0.00109 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015440 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior frontooccipital fasciculus R — — partial R²: 0.00081 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015441 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Anterior thalamic radiation right — — partial R²: 0.00102 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015442 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Forceps minor — — partial R²: 0.00115 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015443 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior longitudinal fasciculus L — — partial R²: 0.00099 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015444 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Superior thalamic radiation R — — partial R²: 0.00131 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015445 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: ICA component_83 — — partial R²: 0.00079 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015446 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: ICA component_104 — — partial R²: 0.00119 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015447 PGS002789
(MDD_SDPR)
 PSS009952|
European Ancestry|
10,343 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: ICA component_202 — — partial R²: 0.00058 age, headsize scaling factor, PCs1-10 the observed partial R² were higher than random R²s
PPM015240 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (anxious/depressed) — — partial R²: 0.00486 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015245 PGS002789
(MDD_SDPR)
 PSS009950|
European Ancestry|
2,524 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (attention problems) — — partial R²: 0.00211 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015278 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Psychiatric behavior (aggressive behaviour) — — partial R²: 0.00498 age, PCs1-3 the observed partial R² were higher than random R²s
PPM015298 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (fluid composite) — — partial R²: 0.00067 age, PCs1-3 —
PPM015299 PGS002789
(MDD_SDPR)
 PSS009949|
European Ancestry|
2,198 individuals
 PGP000370 |
Gui Y et al. Transl Psychiatry (2022)
 Reported Trait: Cognitive function (Crystallized composite) — — partial R²: 0.00088 age, PCs1-3 —
PPM016144 PGS003333
(MDD-PRS)
 PSS010048|
European Ancestry|
34,703 individuals
 PGP000399 |
Fang Y et al. Biol Psychiatry (2022)
 Reported Trait: Major Depressive Disorder — — Nagelkerke pseudo-R2: 0.022 — —
PPM017180 PGS003442
(GRS8_MD)
 PSS010155|
Ancestry Not Reported|
117 individuals
 PGP000444 |
Petrican R et al. Sci Rep (2023)
 Reported Trait: Fluid cognition via average SST BOLD activation in adoptees β: 0.064 (0.027) — — — —
PPM017181 PGS003442
(GRS8_MD)
 PSS010156|
Ancestry Not Reported|
4,382 individuals
 PGP000444 |
Petrican R et al. Sci Rep (2023)
 Reported Trait: Fluid cognition via verage SST BOLD activation in non-adoptees β: 0.0 (0.004) — — — —
PPM018200 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00727 PCs 1-10 —
PPM018201 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01033 PCs 1-10 —
PPM018202 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00658 PCs 1-10 —
PPM018204 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00491 PCs 1-10 —
PPM018205 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0241 PCs 1-10 —
PPM018206 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0181 PCs 1-10 —
PPM018207 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01668 PCs 1-20 —
PPM018208 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.02062 PCs 1-20 —
PPM018209 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01847 PCs 1-20 —
PPM018203 PGS003576
(AutoImpAll.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01563 PCs 1-10 —
PPM018210 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01013 PCs 1-10 —
PPM018211 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00938 PCs 1-10 —
PPM018212 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00505 PCs 1-10 —
PPM018213 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00482 PCs 1-10 —
PPM018214 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00405 PCs 1-10 —
PPM018215 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0182 PCs 1-10 —
PPM018216 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0141 PCs 1-10 —
PPM018217 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00953 PCs 1-20 —
PPM018219 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01454 PCs 1-20 —
PPM018218 PGS003577
(AutoImpOnly.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01605 PCs 1-20 —
PPM018271 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01 PCs 1-10 —
PPM018272 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0048 PCs 1-10 —
PPM018273 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01087 PCs 1-10 —
PPM018274 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00943 PCs 1-10 —
PPM018275 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0257 PCs 1-10 —
PPM018276 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0199 PCs 1-10 —
PPM018277 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.02024 PCs 1-20 —
PPM018278 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.02182 PCs 1-20 —
PPM018270 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0038 PCs 1-10 —
PPM018279 PGS003578
(MTAG.All.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01995 PCs 1-20 —
PPM018250 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00955 PCs 1-10 —
PPM018251 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.02257 PCs 1-10 —
PPM018253 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0115 PCs 1-10 —
PPM018254 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01013 PCs 1-10 —
PPM018255 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0204 PCs 1-10 —
PPM018256 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0155 PCs 1-10 —
PPM018257 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01754 PCs 1-20 —
PPM018258 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01951 PCs 1-20 —
PPM018259 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01771 PCs 1-20 —
PPM018252 PGS003579
(MTAG.AllDep.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00435 PCs 1-10 —
PPM018260 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00134 PCs 1-10 —
PPM018262 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00539 PCs 1-10 —
PPM018263 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01207 PCs 1-10 —
PPM018264 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00827 PCs 1-10 —
PPM018265 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0254 PCs 1-10 —
PPM018266 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0207 PCs 1-10 —
PPM018267 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.02512 PCs 1-20 —
PPM018268 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01435 PCs 1-20 —
PPM018269 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.02075 PCs 1-20 —
PPM018261 PGS003580
(MTAG.AllDepEnvs.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0156 PCs 1-10 —
PPM018230 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00169 PCs 1-10 —
PPM018231 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00598 PCs 1-10 —
PPM018232 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00234 PCs 1-10 —
PPM018233 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00581 PCs 1-10 —
PPM018235 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0182 PCs 1-10 —
PPM018236 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0147 PCs 1-10 —
PPM018237 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01186 PCs 1-20 —
PPM018238 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01336 PCs 1-20 —
PPM018239 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01224 PCs 1-20 —
PPM018234 PGS003581
(MTAG.Envs.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00336 PCs 1-10 —
PPM018240 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00305 PCs 1-10 —
PPM018241 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01232 PCs 1-10 —
PPM018242 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00193 PCs 1-10 —
PPM018244 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00819 PCs 1-10 —
PPM018245 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0104 PCs 1-10 —
PPM018246 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0064 PCs 1-10 —
PPM018247 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00441 PCs 1-20 —
PPM018248 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01656 PCs 1-20 —
PPM018249 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01091 PCs 1-20 —
PPM018243 PGS003582
(MTAG.FamHist.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00709 PCs 1-10 —
PPM018220 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00551 PCs 1-10 —
PPM018221 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01906 PCs 1-10 —
PPM018222 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00363 PCs 1-10 —
PPM018223 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00962 PCs 1-10 —
PPM018224 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00957 PCs 1-10 —
PPM018226 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0145 PCs 1-10 —
PPM018227 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01562 PCs 1-20 —
PPM018228 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01608 PCs 1-20 —
PPM018229 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01652 PCs 1-20 —
PPM018225 PGS003583
(MTAG.GPpsy.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0198 PCs 1-10 —
PPM018180 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00898 PCs 1-10 —
PPM018181 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00726 PCs 1-10 —
PPM018182 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0044 PCs 1-10 —
PPM018183 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00842 PCs 1-10 —
PPM018184 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00537 PCs 1-10 —
PPM018185 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0207 PCs 1-10 —
PPM018187 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00508 PCs 1-20 —
PPM018188 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0071 PCs 1-20 —
PPM018189 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01722 PCs 1-20 —
PPM018186 PGS003584
(SoftImpAll.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.016 PCs 1-10 —
PPM018190 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010946|
African Ancestry|
1,158 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01492 PCs 1-10 —
PPM018191 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010947|
Additional Asian Ancestries|
1,996 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00395 PCs 1-10 —
PPM018192 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010948|
European Ancestry|
14,388 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00491 PCs 1-10 —
PPM018193 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010949|
Hispanic or Latin American Ancestry|
2,454 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00837 PCs 1-10 —
PPM018194 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010950|
East Asian Ancestry|
10,502 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.00546 PCs 1-10 —
PPM018196 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010955|
European Ancestry|
23,351 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0121 PCs 1-10 —
PPM018197 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010951|
African Ancestry|
687 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01598 PCs 1-20 —
PPM018198 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010952|
Additional Asian Ancestries|
334 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.02548 PCs 1-20 —
PPM018199 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010953|
European Ancestry|
10,193 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.01284 PCs 1-20 —
PPM018195 PGS003585
(SoftImpOnly.LifetimeMDD)
 PSS010954|
European Ancestry|
42,250 individuals
 PGP000461 |
Dahl A et al. bioRxiv (2022)
|Pre		 Reported Trait: Major depressive disorder — — R²: 0.0176 PCs 1-10 —
PPM020721 PGS004591
(PRS17_MDD)
 PSS011382|
Multi-ancestry (including European)|
354,897 individuals
 PGP000570 |
Li D et al. BMC Med (2023)
 Reported Trait: Major depressive disorder with PM2.5 air pollution — — Hazard ratio (HR, PRS in top tertile and high PM2.5 exposure vs PRS in bottom tertile and low PM2.5 exposure): 1.34 [1.23, 1.46] Age, gender, ethnicity, education level, employment status, household income, and Townsend deprivation index —
PPM020720 PGS004591
(PRS17_MDD)
 PSS011382|
Multi-ancestry (including European)|
354,897 individuals
 PGP000570 |
Li D et al. BMC Med (2023)
 Reported Trait: Major depressive disorder — — Hazard ratio (HR, per IQR change in PRS): 1.1 [1.07, 1.12] Age, gender, ethnicity, education level, employment status, household income, Townsend deprivation index, genotyping batch, and first 10 PCs —
PPM020984 PGS004759
(depression_PRSmix_eur)
 PSS011465|
European Ancestry|
9,462 individuals
 PGP000604 |
Truong B et al. Cell Genom (2024)
 Reported Trait: Depression — — Incremental R2 (Full model versus model with only covariates): 0.016 [0.011, 0.021] age, sex, PC1, PC2, PC3, PC4, PC5, PC6, PC7, PC8, PC9, PC10 Incremental R2 (Full model versus model with only covariates)
PPM020985 PGS004760
(depression_PRSmixPlus_eur)
 PSS011465|
European Ancestry|
9,462 individuals
 PGP000604 |
Truong B et al. Cell Genom (2024)
 Reported Trait: Depression — — Incremental R2 (Full model versus model with only covariates): 0.024 [0.018, 0.03] age, sex, PC1, PC2, PC3, PC4, PC5, PC6, PC7, PC8, PC9, PC10 Incremental R2 (Full model versus model with only covariates)
PPM021252 PGS004885
(INTERVENE_MegaPRS_MDD)
 PSS011614|
European Ancestry|
37,136 individuals
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Reported Trait: Incident MDD HR: 1.18 [1.16, 1.2] C-index: 0.56 [0.55, 0.56] — PCs 1-10 —
PPM021253 PGS004885
(INTERVENE_MegaPRS_MDD)
 PSS011613|
European Ancestry|
69,715 individuals
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Reported Trait: Incident MDD HR: 1.27 [1.23, 1.31] C-index: 0.57 [0.56, 0.58] — PCs 1-10 —
PPM021254 PGS004885
(INTERVENE_MegaPRS_MDD)
 PSS011612|
European Ancestry|
29,427 individuals
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Reported Trait: Incident MDD HR: 1.27 [1.23, 1.32] C-index: 0.58 [0.57, 0.59] — PCs 1-10 —
PPM021255 PGS004885
(INTERVENE_MegaPRS_MDD)
 PSS011610|
European Ancestry|
44,188 individuals
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Reported Trait: Incident MDD HR: 1.17 [1.12, 1.22] — — PCs 1-10 —
PPM021256 PGS004885
(INTERVENE_MegaPRS_MDD)
 PSS011611|
European Ancestry|
7,018 individuals
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Reported Trait: Incident MDD HR: 1.36 [1.21, 1.53] C-index: 0.62 [0.58, 0.65] — PCs 1-10 —
PPM021257 PGS004885
(INTERVENE_MegaPRS_MDD)
 PSS011609|
European Ancestry|
412,090 individuals
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Reported Trait: Incident MDD HR: 1.24 [1.23, 1.25] C-index: 0.58 [0.58, 0.58] — PCs 1-10 —
PPM021258 PGS004885
(INTERVENE_MegaPRS_MDD)
 PSS011608|
European Ancestry|
199,868 individuals
 PGP000618 |
Jermy B et al. Nat Commun (2024)
 Reported Trait: Incident MDD HR: 1.15 [1.14, 1.16] C-index: 0.55 [0.55, 0.55] — PCs 1-10 —

Evaluated Samples

PGS Sample Set ID
(PSS) 		Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS009949 NIH Toolbox was used to measure cognition in ABCD. Children’s problems and competencies were rated using the parent-reported Children Behavior Checklist (CBCL). Details of the ABCD MRI data acquisition and analysis have been published previously. — 2,198 individuals,
0.0 % Male samples
 Mean = 9.89 years
Sd = 0.61 years		 European — ABCD —
PSS011465 — — 9,462 individuals — European — AllofUs —
PSS010946 — —
[
  • 90 cases
  • , 1,068 controls
]
 Range = [18.0, 86.0] years African unspecified
(Black)		 — UCLA —
PSS010947 — —
[
  • 91 cases
  • , 1,905 controls
]
 Range = [18.0, 86.0] years Asian unspecified
(Asian)		 — UCLA —
PSS010948 — —
[
  • 1,428 cases
  • , 12,960 controls
]
 Range = [18.0, 86.0] years European — UCLA —
PSS010949 — —
[
  • 199 cases
  • , 2,255 controls
]
 Range = [18.0, 86.0] years Hispanic or Latin American
(Latino)		 — UCLA —
PSS010950 — —
[
  • 5,282 cases
  • , 5,220 controls
]
 Range = [30.0, 60.0] years East Asian
(Han Chinese)		 — CONVERGE —
PSS010951 — —
[
  • 122 cases
  • , 565 controls
]
 Range = [37.0, 74.0] years African unspecified
(African)		 — UKB —
PSS000294 Participants completed an online follow-up questionnaire assessing common mental health disorders, including MDD symptoms. Phenotypes were derived from this questionnaire. Individuals with probable MDD met lifetime criteria based on their responses to questions derived from the Composite International Diagnostic Interview. We excluded cases if they self-reported diagnoses of schizophrenia, other psychoses, or bipolar disorder. Controls were excluded if they self-reported any mental illness, taking any drug with an antidepressant indication, or had been hospitalised with a mood disorder or met previously-defined criteria for a mood disorder. —
[
  • 29,475 cases
  • , 63,482 controls
]
,
45.0 % Male samples
 Range = [46.0, 80.0] years European — UKB —
PSS010952 — —
[
  • 62 cases
  • , 272 controls
]
 Range = [37.0, 74.0] years Asian unspecified
(Asian)		 — UKB —
PSS010953 — —
[
  • 2,741 cases
  • , 7,452 controls
]
 Range = [37.0, 74.0] years European — UKB —
PSS010954 — —
[
  • 18,879 cases
  • , 23,371 controls
]
 Range = [8.0, 32.0] years European
(Danish)		 — iPSYCH —
PSS010955 — —
[
  • 8,188 cases
  • , 15,163 controls
]
 Range = [8.0, 35.0] years European
(Danish)		 — iPSYCH —
PSS010155 — — 117 individuals,
50.0 % Male samples
 Mean = 9.96 years Not reported — NR ABCD
PSS010048 phecode 296.22 —
[
  • 13,850 cases
  • , 20,853 controls
]
 — European — MGI —
PSS001185 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001186 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001187 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001188 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001189 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001190 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001191 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001192 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001193 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001194 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001195 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001196 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001197 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001198 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001199 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001200 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001201 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001202 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001203 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001204 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001205 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001206 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001207 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001208 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001209 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001210 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001211 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001212 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001213 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001214 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001215 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001216 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001217 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001218 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001219 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001220 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001221 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001222 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001223 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001224 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001225 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001226 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001227 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001228 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001229 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001230 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001231 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001232 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001233 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001234 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001235 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001236 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001237 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001238 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001239 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001240 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001241 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001242 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001243 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001244 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001245 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001246 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001247 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001248 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001249 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001250 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001251 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001252 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001253 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001254 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001255 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001256 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001257 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001258 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001259 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001260 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001261 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001262 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001263 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001264 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001265 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001266 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001267 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001268 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001269 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001270 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001271 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001272 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001273 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001274 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001275 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001276 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001277 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001278 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001279 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001280 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001281 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001282 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001283 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001284 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS009950 NIH Toolbox was used to measure cognition in ABCD. Children’s problems and competencies were rated using the parent-reported Children Behavior Checklist (CBCL). Details of the ABCD MRI data acquisition and analysis have been published previously. — 2,524 individuals,
100.0 % Male samples
 Mean = 9.92 years
Sd = 0.62 years		 European — ABCD —
PSS009951 Fluid intelligence test — 78,561 individuals,
0.0 % Male samples
 Mean = 57.46 years
Sd = 8.08 years		 European — UKB —
PSS009952 imaging-derived phenotypes (IDPs) generated by an image-processing pipeline developed and ran on behalf of the UKB — 10,343 individuals,
0.0 % Male samples
 Mean = 63.13 years
Sd = 7.3 years		 European — UKB —
PSS009939 — — 39,444 individuals — European
(Finnish)		 — FinnGen —
PSS009953 Fluid intelligence test — 68,614 individuals,
100.0 % Male samples
 Mean = 58.39 years
Sd = 8.36 years		 European — UKB —
PSS001295 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001296 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001297 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001298 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001299 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001300 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001301 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001302 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001303 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001304 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001305 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001306 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001307 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001308 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001309 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001310 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001311 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001312 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001313 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001314 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001315 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001316 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001317 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001318 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001319 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001320 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS000250 — —
[
  • 14,696 cases
  • , 22,013 controls
]
 — European — 15 cohorts
  • BOMA
  • ,CoLaus
  • ,Edinburgh
  • ,GenPOD
  • ,GenRED
  • ,MARS
  • ,MPIP
  • ,NESDA
  • ,QIMR
  • ,RADIANT
  • ,RS
  • ,SHIP
  • ,STAR*D
  • ,TwinGene
  • ,i2b2
 Part of PGC29 (PMID: 29700475)
PSS001321 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001323 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001324 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001325 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001326 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001327 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001328 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001329 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001330 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001331 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001332 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001333 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001334 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001335 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001336 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001337 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001338 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001339 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001340 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001341 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001342 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001343 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001344 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001345 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001346 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001347 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001348 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001349 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001350 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001351 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001352 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001353 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001354 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001355 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001356 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001357 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001358 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001359 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001360 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001361 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001362 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001363 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001364 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001365 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001366 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001367 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001368 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001369 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001370 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001371 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001372 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001373 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001374 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001375 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001376 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001377 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001378 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001379 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001380 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001381 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001382 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001383 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001384 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001385 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001386 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001387 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001388 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001389 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001390 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001391 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001392 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001393 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001394 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001395 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001396 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001397 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001398 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001399 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001400 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001401 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001402 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001403 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001404 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001405 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001406 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001407 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001408 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001409 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001410 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001411 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001412 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001413 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001414 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001415 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001416 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001417 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001418 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001419 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001420 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001421 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001422 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001423 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001424 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001425 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001426 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001427 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001428 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001429 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001430 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001431 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001432 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001433 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001434 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS001435 — —
[
  • 140 cases
  • , 1,517 controls
]
 — European — AGDS —
PSS001436 — —
[
  • 367 cases
  • , 2,218 controls
]
 — European — AGDS —
PSS001437 — —
[
  • 489 cases
  • , 2,035 controls
]
 — European — AGDS —
PSS001438 — —
[
  • 382 cases
  • , 1,613 controls
]
 — European — AGDS —
PSS001439 — —
[
  • 712 cases
  • , 3,653 controls
]
 — European — AGDS —
PSS001440 — —
[
  • 583 cases
  • , 3,087 controls
]
 — European — AGDS —
PSS001441 — —
[
  • 186 cases
  • , 1,801 controls
]
 — European — AGDS —
PSS001442 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS001443 — —
[
  • 1,020 cases
  • , 4,699 controls
]
 — European — AGDS —
PSS001444 — —
[
  • 794 cases
  • , 3,173 controls
]
 — European — AGDS —
PSS011608 — —
[
  • 51,443 cases
  • , 148,425 controls
]
 — European — EB —
PSS011609 — —
[
  • 46,909 cases
  • , 365,181 controls
]
 — European — FinnGen —
PSS011610 — —
[
  • 2,526 cases
  • , 41,662 controls
]
 — European — G&H —
PSS011611 — —
[
  • 273 cases
  • , 6,745 controls
]
 — European — GS:SFHS —
PSS011612 — —
[
  • 3,349 cases
  • , 26,078 controls
]
 — European — GEL —
PSS011613 — —
[
  • 4,671 cases
  • , 65,044 controls
]
 — European — HUNT —
PSS011614 — —
[
  • 12,774 cases
  • , 24,362 controls
]
 — European — MGBB —
PSS011382 — —
[
  • 14,172 cases
  • , 326,236 controls
]
 — European — UKB —
PSS011382 — —
[
  • 165 cases
  • , 4,966 controls
]
 — Asian unspecified — UKB —
PSS011382 — —
[
  • 91 cases
  • , 3,014 controls
]
 — African unspecified — UKB —
PSS011382 — —
[
  • 8 cases
  • , 775 controls
]
 — East Asian
(Chinese)		 — UKB —
PSS011382 — —
[
  • 274 cases
  • , 5,196 controls
]
 — Not reported — UKB —
PSS001322 — —
[
  • 236 cases
  • , 1,344 controls
]
 — European — AGDS —
PSS010156 — — 4,382 individuals,
50.0 % Male samples
 Mean = 9.94 years Not reported — NR ABCD
PSS000984 — — 62 individuals,
0.0 % Male samples
 — European, Hispanic or Latin American, African unspecified, Asian unspecified, NR — NR —
PSS000985 — — 63 individuals,
0.0 % Male samples
 — European, Hispanic or Latin American, African unspecified, Asian unspecified, NR — NR —
PSS000986 — — 73 individuals,
0.0 % Male samples
 — European, Hispanic or Latin American, African unspecified, Asian unspecified, NR — NR —